# Vor Biopharma Inc. — Form D

Vor Biopharma Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-07-10. The offering totals $110.1M, of which $110.1M was reported sold. Industry: Other.

## Offering

- Filed: 2020-07-10
- Form: D
- Accession: 0001817229-20-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $110.1M
- Amount sold: $110.1M
- Investors: 33
- Date of first sale: 2020-06-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-370729

## Issuer

- Name: Vor Biopharma Inc.
- CIK: 0001817229
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 100 Cambridgepark Drive, CAMBRIDGE, MA, 02140
- Phone: 617-655-6580

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Robert Ang | Director | Cambridge, MA |
| Sven Lundberg | Director | Cambridge, MA |
| Kush Parmar | Director | San Francisco, CA |
| Joshua Resnick | Director | New York, NY |
| Robert Ang | Executive Officer | Cambridge, MA |
| Nathan Jorgensen | Executive Officer | Cambridge, MA |
| Amy Mendel | Executive Officer | Cambridge, MA |

## More

- [CIK 1817229 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1817229&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001817229-20-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.